Showing results (621-630 of 836) with videos related to

Sort By:
Pageof 84
Hypertension (Dallas, Tex. : 1979)|March 21, 2012
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trialMichael H Alderman, Linda B Piller, Charles E Ford, et al.
Archives of Internal Medicine|April 27, 2005
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman, Sara Pressel, Barry R Davis, et al.
JACC. Cardiooncology|May 14, 2025
Blood Pressure Lowering and Risk of Cancer: Individual Participant-Level Data Meta-Analysis and Mendelian Randomization StudiesMilad Nazarzadeh, Emma Copland, Karl Smith Byrne, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare DiseasesAdam Wanner, Stephen C Groft, J Russell Teagarden, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|May 23, 2013
[Diagnosis of obscure gastrointestinal bleeding among different age groups by double balloon enteroscope]Liang Zhao, Yi-Juan Ding, Hong-Gang Yu, et al.
Cancer Science|April 12, 2019
Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer riskWenjun Yang, Hongliang Liu, Bensong Duan, et al.
Experimental Neurology|August 9, 2025
Ketogenic diet and quercetin promote the recovery of motor function in rats with spinal cord injuryXuhua Liu, Xinfang Liu, Jinbo Lin, et al.
International Journal of Cancer|September 28, 2018
Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survivalDanwen Qian, Hongliang Liu, Xiaomeng Wang, et al.
JAMA Neurology|April 9, 2014
Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experienceSotirios A Parashos, Sheng Luo, Kevin M Biglan, et al.
Frontiers in Pharmacology|March 7, 2022
Abiraterone, Orteronel, Enzalutamide and Docetaxel: Sequential or Combined Therapy?Ming-Kun Chen, Zhi-Jian Liang, Dao-Sheng Luo, et al.
Pageof 84